GeneDx Announces Preliminary 2023 Financial Results
Expects to exceed revised 2023 revenue guidance with fourth quarter 2023 revenue from continuing operations1 of more than $57M with […]
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
VANCOUVER, British Columbia, Jan. 08, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), […]
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) — Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit Altamira’s […]
Brera Holdings PLC Announces Six-Month Financial Results, Active Search for Italian Serie B Football Club Target
DUBLIN, Jan. 08, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings”, “Brera” or the “Company”) (Nasdaq: BREA) is focused […]
Roadzen Appoints Jean-Noël Gallardo as Global Chief Financial Officer
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN), a global pioneer in AI-driven insurance and mobility […]
TSX News -
HEALWELL AI to Participate in Upcoming Investor Conferences
Attending the 42nd Annual J.P. Morgan Healthcare Conference on January 8 to January 11, 2024, in San Francisco, California In-person […]
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular […]
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB) (Standard BioTools or the Company), […]
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans
Fourth quarter revenue expected to be $11.2 million to $11.3 million, representing growth of 56% to 58% Full year revenue […]
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
MALVERN, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology […]
